Erlotinib Re-Challenge for Recurrent EGFR-mutant Lung Cancer in Patients Who Previously Received Adjuvant Erlotinib or Gefitinib
Clinical trial NCT01189435 · TERMINATED
Trial details
- NCT number
- NCT01189435
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-08-01
- Primary completion
- 2012-01-01
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.